Comment on an article: "High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia".
作者信息
Ibrahimagić Omer Ć, Kunić Suljo
机构信息
Department of Neurology, University Cinical Centre Tuzla, 75000 Tuzla, Bosnia and Herzegovina.
Department of Neurology, Primary Health Care Centre Tuzla, 75000 Tuzla, Bosnia and Herzegovina.
出版信息
Med Hypotheses. 2020 Dec;145:110338. doi: 10.1016/j.mehy.2020.110338. Epub 2020 Oct 7.
Abstract
摘要
相似文献
1
Comment on an article: "High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia".对一篇文章的评论：“高剂量叶酸是肺动脉高压的一种潜在治疗方法，包括与新冠病毒肺炎相关的肺动脉高压”。
Med Hypotheses. 2020 Dec;145:110338. doi: 10.1016/j.mehy.2020.110338. Epub 2020 Oct 7.
2
High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia.大剂量叶酸是肺动脉高压的一种潜在治疗方法，包括与 COVID-19 肺炎相关的情况。
Med Hypotheses. 2020 Oct;143:110142. doi: 10.1016/j.mehy.2020.110142. Epub 2020 Jul 26.
3
Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor.肺动脉血栓形成作为新型冠状病毒肺炎肺部疾病的重要并发症：致编辑的信
Virchows Arch. 2020 Sep;477(3):467-468. doi: 10.1007/s00428-020-02896-4.
4
Integrated clinical role of echocardiography in patients with COVID-19 disease.超声心动图在新冠病毒疾病患者中的综合临床作用
Heart. 2020 Dec;106(23):1864. doi: 10.1136/heartjnl-2020-318309. Epub 2020 Oct 14.
5
Identifying phenotypes of COVID-19, defining their pathogenesis, and targeting treatments could improve outcomes.识别新冠病毒疾病（COVID-19）的表型，明确其发病机制，并针对性地进行治疗，可能会改善治疗结果。
Respir Physiol Neurobiol. 2020 Sep;280:103477. doi: 10.1016/j.resp.2020.103477. Epub 2020 Jun 24.
6
Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable?叶酸作为羟氯喹预防 COVID-19 的对照临床试验中的安慰剂：在科学上是否合理？
Med Hypotheses. 2021 Apr;149:110539. doi: 10.1016/j.mehy.2021.110539. Epub 2021 Feb 20.
7
Integrated clinical role of echocardiography in patients with COVID-19.超声心动图在新冠病毒肺炎患者中的综合临床作用
Heart. 2020 Dec;106(23):1864-1865. doi: 10.1136/heartjnl-2020-318310. Epub 2020 Oct 14.
8
The pulmonary circuit dynamics in COVID-19!新型冠状病毒肺炎中的肺循环动力学！
J Anesth. 2021 Feb;35(1):161. doi: 10.1007/s00540-020-02869-6. Epub 2020 Oct 31.
9
COVID-19 and Pulmonary Arterial Hypertension: Early Data and Many Questions.新型冠状病毒肺炎与肺动脉高压：早期数据及诸多问题
Ann Am Thorac Soc. 2020 Dec;17(12):1528-1530. doi: 10.1513/AnnalsATS.202008-1014ED.
10
Differentiating COVID-19 Pneumonia From Acute Respiratory Distress Syndrome and High Altitude Pulmonary Edema: Therapeutic Implications.鉴别新型冠状病毒肺炎与急性呼吸窘迫综合征和高原肺水肿：治疗意义
Circulation. 2020 Jul 14;142(2):101-104. doi: 10.1161/CIRCULATIONAHA.120.047915. Epub 2020 May 5.
引用本文的文献
1
Clinical Evidence on the Potential Beneficial Effects of Diet and Dietary Supplements against COVID-19 Infection Risk and Symptoms' Severity.临床证据表明，饮食和膳食补充剂可能对预防 COVID-19 感染风险和减轻症状严重程度有益。
Med Sci (Basel). 2024 Feb 17;12(1):11. doi: 10.3390/medsci12010011.
本文引用的文献
1
High dose folic acid is a potential treatment for pulmonary hypertension, including when associated with COVID-19 pneumonia.大剂量叶酸是肺动脉高压的一种潜在治疗方法，包括与 COVID-19 肺炎相关的情况。
Med Hypotheses. 2020 Oct;143:110142. doi: 10.1016/j.mehy.2020.110142. Epub 2020 Jul 26.
2
Homocysteine: Its Possible Emerging Role in At-Risk Population Groups.同型半胱氨酸：其在高危人群中的潜在作用。
Int J Mol Sci. 2020 Feb 20;21(4):1421. doi: 10.3390/ijms21041421.
3
Homocysteine and age-associated disorders.同型半胱氨酸与年龄相关疾病。
Ageing Res Rev. 2019 Jan;49:144-164. doi: 10.1016/j.arr.2018.10.010. Epub 2018 Nov 2.
4
Homocysteine and homocysteine-related compounds: an overview of the roles in the pathology of the cardiovascular and nervous systems.同型半胱氨酸及同型半胱氨酸相关化合物：心血管系统和神经系统病理学中作用的概述
Can J Physiol Pharmacol. 2018 Oct;96(10):991-1003. doi: 10.1139/cjpp-2018-0112. Epub 2018 Aug 21.
5
Homocysteine-Induced Endothelial Dysfunction.同型半胱氨酸诱导的内皮功能障碍。
Ann Nutr Metab. 2015;67(1):1-12. doi: 10.1159/000437098. Epub 2015 Jul 18.
6
Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients.左旋多巴治疗的帕金森病患者高同型半胱氨酸血症复发。
Eur J Neurol. 2010 May;17(5):661-5. doi: 10.1111/j.1468-1331.2009.02894.x. Epub 2009 Dec 27.
7
Homocysteine lowering with folic acid and B vitamins in vascular disease.在血管疾病中使用叶酸和B族维生素降低同型半胱氨酸水平
N Engl J Med. 2006 Apr 13;354(15):1567-77. doi: 10.1056/NEJMoa060900. Epub 2006 Mar 12.
8
Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.降低同型半胱氨酸预防心血管事件的试验：大型随机试验的设计与效能综述
Am Heart J. 2006 Feb;151(2):282-7. doi: 10.1016/j.ahj.2005.04.025.
9
Plasma endothelin-1, homocysteine and serum nitric oxide values in patients with left-to-right shunt.左向右分流患者的血浆内皮素-1、同型半胱氨酸及血清一氧化氮值
Indian Heart J. 2004 Nov-Dec;56(6):653-7.
10
Facts and recommendations about total homocysteine determinations: an expert opinion.关于总同型半胱氨酸测定的事实与建议：专家意见
Clin Chem. 2004 Jan;50(1):3-32. doi: 10.1373/clinchem.2003.021634.
Zotero 插件